|
⚠️ Professional Use Only This content is intended exclusively for licensed medical professionals. It does not constitute clinical advice. Always follow applicable regulations and guidelines in your jurisdiction. |
|
✍️ Written by: Celmade Editorial Team | AI-Assisted Content 🔬 Medically Reviewed by: Stella Williams, Medical Aesthetic Injector 📅 Published: April 27th, 2026 | Last Reviewed: April 27th, 2026 🔗 View Reviewer Full Profile → celmade.co/pages/team-stella-williams |
|
📌 Editorial Note: This article was drafted with AI assistance and reviewed, fact-checked, and approved by Stella Williams, a qualified Medical Aesthetic Injector. All clinical claims are supported by cited references. |
As PDRN (polydeoxyribonucleotide) products enter mainstream aesthetic practice, one of the most common questions practitioners ask is deceptively simple: for a given patient, should I use PDRN or a HA skin booster? The question is deceptive because it implies a binary choice where the more useful clinical framing is a spectrum — with most patients sitting somewhere in the middle where both could offer benefit, and the skill lying in knowing which mechanism addresses their dominant concern more directly.
This guide provides a structured clinical comparison that goes beyond mechanism descriptions and directly addresses the decision problem: given a specific patient presentation, what do you choose, why, and when is the answer 'both'? It draws on the comparison frameworks developed across the Skin Booster and PDRN content clusters and consolidates them into a practical patient-facing decision tool.
For the full mechanism science behind each category, see the Complete Practitioners Guide to Polynucleotides and PDRN and the Complete Practitioner's Guide to Skin Boosters. For high vs low MW HA science, see our Molecular Weight HA guide.
The Starting Point: Two Fundamentally Different Mechanisms
The comparison between PDRN and HA skin boosters begins at the mechanism level — because the mechanism determines what each treatment can and cannot do, and therefore which patient profiles benefit most from each.
|
Property |
PDRN / Polynucleotides |
HA Skin Boosters |
|
Primary action |
Biological signalling — activates adenosine A2A receptors on fibroblasts, endothelial cells, and immune cells to trigger a cellular regenerative programme |
Physical chemistry — introduces hyaluronic acid into the dermis, which binds and holds water and mechanically stimulates fibroblasts through tissue distension |
|
Hydration effect |
Indirect only — improves vascular supply and tissue environment over time. Does not directly add water to the dermis. |
Direct and immediate — HA binds up to 1,000× its weight in water. Creates a dermal hydration depot visible as improved turgor within days. |
|
Collagen induction |
Strong and direct — A2AR activation drives fibroblast proliferation and upregulates collagen and elastin synthesis pathways |
Moderate and indirect — mechanical fibroblast stimulation and CD44/RHAMM receptor activation trigger some collagen production, amplified with lower MW HA |
|
Angiogenesis |
Yes — VEGF upregulation creates new perifollicular and intradermal capillaries. Unique to PDRN among aesthetic injectables. |
No — HA does not stimulate new blood vessel formation |
|
Anti-inflammatory effect |
Yes — A2AR activation suppresses pro-inflammatory cytokines. Useful for inflamed or chronically stressed skin. |
Minimal — HA has mild anti-inflammatory properties via HA receptor signalling but this is not a primary mechanism |
|
Hydrophilicity / oedema risk |
Zero — no water-attracting mechanism. Safe in all zones including periorbital. |
Moderate to high (product dependent) — risk of post-treatment swelling in zones with limited drainage, especially periorbital |
|
Onset of visible improvement |
Slower — 2–4 weeks after first session as collagen builds. Patients expect gradual improvement. |
Faster — hydration improvement within days of first session. Radiance visible within 1–2 weeks. |
|
Scalp / hair application |
Yes — VEGF angiogenesis and papilla cell support make PDRN highly suitable for scalp and hair rejuvenation. |
No — HA skin boosters are not used for scalp or hair rejuvenation |
|
Combination with each other |
Excellent — complementary mechanisms. No tissue conflict. Can be combined in same session or alternate sessions. |
Excellent — the most naturally complementary pairing in injectable aesthetics |
Where Each Treatment Has a Clear Clinical Advantage
Before reaching the nuanced cases where the choice is less obvious, it is useful to identify where each product category has a clear, unambiguous advantage:
|
WHERE PDRN IS THE CLEAR CHOICE |
|
Periorbital zone (under-eye): PDRN carries zero hydrophilicity risk — it cannot cause the post-treatment puffiness that standard HA skin boosters predictably cause in the thin-skinned, drainage-limited periorbital zone. For practitioners who want to treat under-eye skin quality, PDRN is the mechanistically correct primary product. Significant photoageing with collagen deficit: When the dominant pathology is genuine collagen loss rather than surface dehydration, PDRN's direct fibroblast proliferation mechanism addresses the root cause more effectively than HA hydration. Photoaged skin needs regeneration, not just hydration. Scalp and hair rejuvenation: PDRN is the only mainstream aesthetic injectable that stimulates angiogenesis via VEGF upregulation — directly addressing the perifollicular vascular impairment that drives follicle miniaturisation. HA skin boosters have no role in hair rejuvenation. Post-procedure recovery (post-laser, post-peel): PDRN's anti-inflammatory A2AR effect and wound healing acceleration make it the mechanistically ideal injectable for the post-procedure recovery phase. The same evidence base that establishes PDRN in wound healing applies directly here. Inflamed or sensitised skin: A2AR activation is specifically anti-inflammatory. For patients with rosacea, chronic skin inflammation, or post-procedural sensitivity, PDRN supports rather than challenges the skin's inflammatory state. Acne scar improvement: Fibroblast proliferation and collagen remodelling from PDRN produce gradual improvement in superficial scar depth that HA hydration cannot replicate. |
|
WHERE HA SKIN BOOSTERS ARE THE CLEAR CHOICE |
|
Dehydrated skin — rapid hydration and radiance: Nothing delivers dermal hydration as quickly and directly as HA. A patient presenting with dehydrated, dull skin who wants visible improvement within 1–2 weeks of their first session will be better served by HA than PDRN in the short term. The HA hydration depot is visible and felt within days. Younger patients with no significant collagen deficit (25–38): When the concern is primarily dehydration and dullness rather than structural collagen loss, HA skin boosters address the presenting concern directly. The regenerative mechanism of PDRN adds limited additional benefit when fibroblasts are already healthy and active. Immediate result before an event: For a patient preparing for a wedding, photoshoot, or important event 2–3 weeks away, HA skin booster delivers visible improvement on the timeline they need. PDRN's regenerative mechanism requires more time to show results. First-time injectable patients wanting a gentle introduction to biorevitalisation: HA skin boosters are familiar, widely understood, and have excellent safety profiles. For a patient new to injectables who wants to 'try something for skin quality', the HA skin booster is a lower-commitment starting point that demonstrates biorevitalisation efficacy before introducing PDRN. Patients prioritising immediate skin feel and texture: The tactile improvement in skin feel — the 'plumpness' and elasticity that patients often describe immediately after skin booster treatment — comes from HA's water-holding depot. PDRN does not produce this immediate tactile change. |
The Nuanced Middle: Most Patients Benefit from Both
The majority of patients presenting for biorevitalisation treatment have both dehydration and some degree of collagen deficit — they need both the water-holding depot of HA and the regenerative stimulus of PDRN. The clinical skill is not choosing one over the other but understanding how to deploy both most effectively:
|
Patient Profile |
Dominant Need |
Primary Product |
Secondary Product |
Protocol Note |
|
25–38, dehydrated skin, no structural concern |
Hydration |
HA skin booster |
Optional PDRN addition after 2+ induction sessions if collagen support desired |
Start with HA. Add PDRN if the patient wants to progress toward prevention after experiencing the HA result. |
|
38–50, early ageing, mixed concern |
Both hydration and regeneration |
Dual MW HA skin booster OR HA+PN hybrid product |
OR alternate HA and PDRN sessions through the induction course |
This is the strongest indication for a dual MW Korean product that delivers both mechanisms. Or: HA session 1, PDRN session 2, HA session 3. |
|
45–65, photoageing, significant collagen loss |
Regeneration primary, hydration secondary |
PDRN as primary |
HA skin booster at same or alternate sessions for hydration support |
PDRN sessions as the core regenerative course. HA skin booster added in the same session (or alternate session) to provide the hydration benefit the patient also needs. |
|
Any age, periorbital concern + full face |
Periorbital: regeneration only. Full face: hydration + regeneration |
PDRN for periorbital zone |
HA skin booster for the rest of the face (nappage — avoiding the periorbital zone) |
Different products for different zones in the same session. PDRN periorbital (5–10 points, 0.005–0.01ml), HA skin booster full face (40–60 points, 0.01–0.02ml), avoiding overlap. |
|
Post-laser recovery |
Regeneration + wound healing support |
PDRN as primary post-procedure support |
HA skin booster added at session 2 once acute recovery phase complete |
PDRN first for anti-inflammatory and wound healing effect. Add HA skin booster at the next session (4–6 weeks post-procedure) for hydration support in the remodelling phase. |
|
Hair thinning (scalp) + skin quality concern (face) |
Scalp: vascular support and follicle stimulation. Face: skin quality |
PDRN for scalp. HA skin booster for face. |
Sessions can be combined — scalp PDRN first, then full-face HA skin booster in the same appointment. |
Efficient same-appointment combination covering both concerns. Total session time: 50–70 minutes. |
Zone-by-Zone Product Selection Reference
Some zones have clear product preferences; others accept both. This zone-by-zone reference provides practical guidance:
|
Treatment Zone |
PDRN Appropriate? |
HA Skin Booster Appropriate? |
Recommended Primary |
Notes |
|
Full face — general skin quality |
Yes |
Yes |
HA skin booster (standard nappage) OR dual MW HA for balanced approach |
Both appropriate. HA gives faster visible hydration; PDRN gives stronger collagen induction. Most practitioners use HA for this zone. |
|
Periorbital / under-eye |
Yes — primary recommendation |
Standard products: No. Specialist low-hydrophilicity HA only. |
PDRN |
PDRN is the safest and most appropriate primary product. Standard HA skin boosters cause puffiness here. |
|
Neck |
Yes |
Yes |
HA skin booster preferred; PDRN as adjunct or alternative |
Both work well on the neck. HA gives immediate hydration; PDRN gives stronger texture improvement. Combination is excellent. |
|
Décolletage |
Yes |
Yes |
HA skin booster (large area, efficient nappage coverage) |
High surface area makes HA more practical for primary treatment. PDRN can be added for enhanced collagen induction. |
|
Perioral (around lips) |
Yes |
Yes |
HA skin booster (low hydrophilicity product) |
Both work for perioral skin quality. PDRN is safer if any hydrophilicity concern. HA gives faster result. |
|
Hands (dorsal) |
Yes |
Yes |
HA skin booster for hydration; PDRN for texture and age spot support |
Both appropriate for hand rejuvenation. HA gives more immediate visible improvement. |
|
Scalp (hair rejuvenation) |
Yes — primary and only option |
No |
PDRN exclusively |
HA skin boosters have no established role in hair rejuvenation. PDRN is the correct injectable category for this zone. |
|
Post-laser / post-peel skin |
Yes — ideal post-procedure support |
Yes (after acute healing phase) |
PDRN first; HA skin booster added from session 2 |
PDRN is mechanistically superior for the wound healing and remodelling phases. HA added for hydration support in the later recovery phase. |
|
Acne scars (superficial) |
Yes — primary choice |
Limited benefit |
PDRN |
Collagen induction from PDRN directly addresses scar architecture. HA hydration does not improve scar depth. |
Cost, Margin, and Practice Economics: Korean Products Across Both Categories
The economics of offering both PDRN and HA skin boosters in the same practice become particularly favourable when Korean CE-marked products are used across both categories. The wholesale cost advantage of Korean products — 30–60% lower than European equivalents at equivalent clinical quality — applies to both:
|
Category |
Product Examples (Korean, CE-marked, via Celmade) |
Approximate Wholesale Cost Advantage vs European Equivalents |
UK Patient Pricing Range |
Margin Profile |
|
Korean HA Skin Boosters |
Single MW and dual MW HA formulations. HA+PN hybrid products. |
30–50% lower than Profhilo and equivalent European products |
£250–£450 per session (full face) |
High — Korean wholesale pricing at competitive patient pricing produces excellent margin |
|
Korean PDRN / PN Products |
PDRN formulations across concentrations. Periorbital-specific products. Scalp-specific concentrations. |
40–60% lower than European PN alternatives (Nucleofill, Plinest, Rejuran) |
£200–£400 per session (face or periorbital). £250–£450 scalp. |
Very high — Korean PDRN is the most cost-effective evidence-supported regenerative injectable available |
|
Korean HA+PN Hybrid Products |
Combined HA+PDRN single-formulation products |
30–50% lower than European hybrids |
£300–£500 per session |
High — single product delivers dual mechanism, reducing per-session product cost while delivering advanced formulation |
|
Building a complete biorevitalisation menu with Korean products: A clinic stocking Korean HA skin boosters (from Celmade's skin booster range), Korean PDRN products (from the PDRN and PN range), and Korean HA+PN hybrid formulations has a complete biorevitalisation menu covering every patient profile — from simple dehydration-priority patients through to advanced regenerative protocols — at a wholesale cost structure that makes both competitive patient pricing and excellent margin simultaneously achievable. This is the economic case for Korean products: not just lower cost, but a better business model for comprehensive biorevitalisation practice. |
The Consultation Decision Tool: Five Questions
At consultation, these five questions — asked in sequence — lead to the correct product selection for almost every patient:
1. What is the patient's primary concern — hydration and radiance, or skin texture and quality improvement? If hydration and immediate radiance: lean toward HA. If texture, collagen, and longer-term quality: lean toward PDRN. If both: dual MW HA or combination protocol.
2. Is the periorbital zone the primary or a significant treatment zone? If yes: PDRN is the primary product for that zone. Standard HA skin boosters should not be used in this zone.
3. What is the patient's age and likely collagen status? Under 38 with good skin structure: HA skin booster appropriate as primary. Over 45 with visible collagen decline: PDRN as primary or dual-mechanism product. 38–45 in the middle: dual MW HA or combination.
4. Is there a scalp or hair rejuvenation component? If yes: PDRN for the scalp, combined with HA or PDRN for the face in the same session.
5. Is there an active inflammatory process, recent procedure, or post-recovery context? If yes: PDRN first, for its anti-inflammatory and wound healing mechanism. HA skin booster added once acute recovery phase complete.
|
The practical recommendation for most clinics: Stock three product tiers: (1) Standard Korean HA skin booster for dehydration-priority and younger patients; (2) Korean PDRN for periorbital, photoageing, post-procedure, and scalp applications; (3) Korean HA+PN hybrid for the broad middle group — early ageing patients who need both mechanisms. This three-tier approach covers every patient profile in a biorevitalisation practice with a product cost structure that makes comprehensive treatment economically viable. |
Explaining the Choice to Patients
Patients arriving for biorevitalisation consultation increasingly arrive with awareness of both HA skin boosters and PN products — often having read about them online or seen them mentioned in aesthetic media. The most common patient question is a variation of: 'Should I have the skin booster or the polynucleotide treatment?' The answer requires a clear, jargon-free explanation:
|
Suggested patient explanation for the PDRN vs HA decision: "Both treatments are injected into the skin to improve its quality — but they work in completely different ways, like two different tools for two slightly different jobs. The HA skin booster is like replenishing a reservoir — it adds a substance that holds a lot of water in the skin, which makes the skin look and feel more hydrated and plump quite quickly. You'll notice the difference within a week or two of the first session. The polynucleotide treatment works more like a renovation — it signals your skin cells to produce more collagen and improve the blood supply to the area. It doesn't add water; it teaches your skin to regenerate itself. The results take longer to appear but they reflect real structural improvement in the skin. For most people, the best approach is actually both — and that's what I'm going to recommend. We can combine them: the HA booster gives you the hydration and immediate glow, and the polynucleotide builds the collagen and quality underneath. Some of our products combine both in the same injection." |
Key Takeaways
• PDRN and HA skin boosters are not direct competitors — they address different but complementary dimensions of skin quality decline. The best clinical outcomes use both, strategically.
• HA skin boosters win on speed and hydration — visible improvement within days, dehydration relief as the primary mechanism. Best for younger patients and hydration-dominant concerns.
• PDRN wins on depth of biological regeneration and zone safety — stronger collagen induction, angiogenesis, anti-inflammatory effect, periorbital safety, and scalp application. Best for photoageing, periorbital, post-procedure, and hair rejuvenation.
• Most patients 38+ benefit from both in a coordinated protocol — dual MW HA products or alternating PDRN and HA sessions address both mechanisms across the induction course.
• Zone selection often determines the product decision — periorbital and scalp → PDRN. Full face, neck, décolletage → HA skin booster (or combination). Post-procedure → PDRN first.
• Korean products cover both categories at superior economics — CE-marked Korean HA skin boosters from Celmade's skin booster range and Korean PDRN from the PDRN and PN range provide a complete biorevitalisation menu with the wholesale cost structure that makes combination protocols commercially viable.
For deeper reading on each category: Complete PDRN Guide, Complete Skin Boosters Guide, Biorevitalisation Patient Selection, and Combining Skin Boosters with Other Treatments.
Frequently Asked Questions
Is PDRN better than HA skin boosters?
Neither is categorically better — they are mechanistically different tools for different clinical situations. PDRN produces stronger collagen induction, has no hydrophilicity risk (making it ideal for periorbital use), and is the correct choice for hair rejuvenation and post-procedure recovery. HA skin boosters produce faster visible hydration improvement and are the more appropriate primary choice for dehydration-dominant concerns in younger patients. For most patients over 38 with combined hydration and collagen concerns, a combination protocol using both produces better outcomes than either alone.
Can I use PDRN and HA skin boosters in the same session?
Yes — this is one of the most clinically sound combination approaches in aesthetic practice. PDRN and HA skin boosters operate through completely different receptor pathways with no tissue conflict. You can treat the periorbital zone with PDRN and the rest of the face with an HA skin booster in the same appointment, or use an HA+PN hybrid product that combines both mechanisms in a single formulation. Korean manufacturers have led the development of these hybrid products for exactly this reason.
Which is more appropriate for a patient in their 30s?
For a patient in their early to mid-30s with primarily dehydration and dullness concerns and good skin structure, an HA skin booster is the appropriate primary product — it addresses the presenting concern directly and produces visible results on the timeline patients in this age group typically expect. If periorbital skin quality is a concern, PDRN should be used for that zone. If the patient is in their late 30s with early texture changes and some visible collagen decline, a dual MW HA product or a combination HA+PDRN protocol is more appropriate.
How do Korean HA skin boosters and Korean PDRN compare in cost?
Both Korean HA skin boosters and Korean PDRN products are available at 30–60% lower wholesale cost than their European equivalents at equivalent clinical quality. Korean HA skin boosters compare to products like Profhilo; Korean PDRN products compare to European PN injectables like Nucleofill or Plinest. In both cases, the Korean products are CE-marked and MFDS-approved, meeting the same regulatory standards. The cost advantage allows practitioners to price competitively, offer combination protocols more accessibly, or maintain higher margins than European products permit. See Celmade's skin booster range and PDRN and PN range for current product availability.
Should I switch a patient from HA skin boosters to PDRN or vice versa?
Switching is rarely the right framing — adding is usually more appropriate. A patient on an HA skin booster maintenance protocol who is showing signs of collagen decline and ageing beyond what hydration alone can address should have PDRN added to their protocol, not substituted for their HA. A patient who has been using PDRN and finds the gradual onset frustrating should have the expectation reset and potentially have HA skin booster added for faster immediate improvement alongside the regenerative PDRN effect. The two treatments complement rather than replace each other in the vast majority of patients.
